Notable gainers among liquid option names this morning include Insulet (PODD) $194.95 +14.26, ResMed (RMD) $232.02 +6.16, Eli Lilly (LLY) $966.64 +16.11, Constellation Energy (CEG) $197.85 +2.96, and Charter (CHTR) $360.70 +5.33.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PODD:
- Street analysts say diabetes stocks âoverreactingâ to Lilly GLP-1 study results
- Diabetes stock selloff on Lilly Surmount-1 results overdone, says Citi
- Insulet opens new manufacturing facility in Malaysia
- ‘Frustrated’ JPMorgan remains buyer of Insulet after Q2 beat
- Insulet price target raised to $220 from $200 at Barclays
